NCT04675515

CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: Dartmouth-Hitchcock Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.

Detailed description

This mixed-methods, observational cohort study will assess intensive tobacco treatment with carbon monoxide monitoring offered to all eligible smoking patients presenting for cancer treatment to the NCCC at our main Lebanon campus and our very rural St. Johnsbury campus. Subjects will not be randomized and study will not be blinded. Cessation rates among the intensive tobacco treatment will be compared to usual care, matched historical controls, and to patients who refuse all tobacco treatment program elements.

Conditions

• Tobacco Use
• Cancer

Interventions

Type	Name	Description
BEHAVIORAL	Intensive Tobacco Treatment	Bi-weekly tobacco treatment counseling and regular carbon monoxide monitoring

Timeline

• Start date: 2021-01-19
• Primary completion: 2023-11-07
• Completion: 2024-02-16
• First posted: 2020-12-19
• Last updated: 2025-07-14

Locations

1 site across 1 country: United States